TEICOINTRA 200
INTRA CRITICAL CARE
Top

TEICOINTRA 200

MRP: 1,250

Packaging: 200mg

Pack Type: injection

Composition:

Teicoplanin IP 200mg

Indication:

This allows holes in the bacterial cell wall, which kills the bacteria. Thus, helps in treating and preventing the spread of infections

Description:

Teicoplanin IP 200 mg is a glycopeptide antibiotic used to treat serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus species. It inhibits bacterial cell wall synthesis, resulting in bactericidal action.

Teicoplanin has a long half-life, allowing once-daily dosing, and can be administered via intravenous (IV) or intramuscular (IM) routes. It is often used as an alternative to Vancomycin, especially in patients at risk of nephrotoxicity.

Indications include:

  • Bone and joint infections

  • Skin and soft tissue infections

  • Bloodstream infections (bacteremia, septicemia)

  • Endocarditis

  • Respiratory tract infections

  • MRSA and multi-drug resistant infections

Tags:

Antibiotic Glycopeptide Class IV/IM Injection MRSA Treatment Hospital Use Broad-Spectrum
  • Effective against MRSA and resistant Gram-positive infections
  • Low nephrotoxicity, safer for kidney-impaired patients
  • Low nephrotoxicity, safer for kidney-impaired patients Once-daily dosing after loading, improving compliance
  • Can be given IV or IM
  • Well tolerated with fewer infusion-related reactions

Usage Information

Dosage

Loading Dose: 400 mg every 12 hours for 3 doses (for serious infections) For mild infections: 6 mg/kg every 12 hours for 3 doses Maintenance Dose: 200 mg once daily (or 6–12 mg/kg/day IV/IM) Duration: Usually 7–14 days depending on the infection type and response Note: Adjust dose in patients with renal impairment.

Side Effects

Common: Injection site pain Rash, pruritus Gastrointestinal upset Serious (rare): Ototoxicity Nephrotoxicity (lower than Vancomycin) Blood dyscrasias (thrombocytopenia, neutropenia) Hypersensitivity reactions

Contraindications

Known allergy to Teicoplanin or other glycopeptides Caution in patients with renal impairment or those on nephrotoxic drugs Not recommended during pregnancy unless necessary Monitor in long-term use (>10 days) for blood count and renal function

TEICOINTRA 200 - INTRA CRITICAL CARE | Intralife Pharmaceuticals | Intralife